These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6558884)

  • 41. [Fetomaternal macrotransfusion--a case report].
    Mickat K; Müller M
    Zentralbl Gynakol; 1972 Sep; 94(39):1272-5. PubMed ID: 4628556
    [No Abstract]   [Full Text] [Related]  

  • 42. [An at-risk pregnancy caused by an irregular complement-activating nonspecific alloantibody in maternal serum].
    Ratei R
    Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):731-2. PubMed ID: 3234706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hemolytic disease in a newborn infant caused by rare maternal anti-erythrocyte antibodies and exchange transfusion with maternal blood frozen earlier].
    Castel A; Drejer GF; Verwey RA
    Ned Tijdschr Geneeskd; 1993 Dec; 137(52):2713-5. PubMed ID: 8289944
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The relationship of transplacental haemorrhage to rhesus immunisation.
    Robinson M; Jakobowicz R; Williams L; Silberman F; Parkinson C
    Aust N Z J Obstet Gynaecol; 1969 Nov; 9(4):232-5. PubMed ID: 4984986
    [No Abstract]   [Full Text] [Related]  

  • 45. [The prevention of the Rh hemolytic disease of the newborn].
    Baumgarten K; Reinold E
    Wien Med Wochenschr; 1970 May; 120(18):319-20. PubMed ID: 5490864
    [No Abstract]   [Full Text] [Related]  

  • 46. Massive fetomaternal hemorrhage: clearance of fetal red blood cells after intravenous anti-D prophylaxis monitored by flow cytometry.
    Larsen R; Berkowicz A; Lousen T; Hedegaard M; Clausen FB; Krog GR; Dziegiel MH
    Transfusion; 2008 Aug; 48(8):1707-12. PubMed ID: 18482192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is the recommended minimum dose of anti-D adequate considering the rise in obesity?
    Regan FA; Naftalin J; Springer V; Paterson-Brown S
    Transfus Med; 2008 Aug; 18(4):266-8. PubMed ID: 18783586
    [No Abstract]   [Full Text] [Related]  

  • 48. [Isoimmunization in the ABO system caused by obstetrician or pregnancy complications (control groups)].
    Sauer J; Kulich V
    Zentralbl Gynakol; 1965 Dec; 87(52):1780-8. PubMed ID: 5885709
    [No Abstract]   [Full Text] [Related]  

  • 49. [A new report of haemolytic disease of the newborn due to IgG anti-M (author's transl)].
    Martin Vega C; Ribera A; Gallart MT; Triginer J
    Sangre (Barc); 1980; 25(3):392-6. PubMed ID: 6968096
    [No Abstract]   [Full Text] [Related]  

  • 50. The pathogenesis of ABO haemolytic disease of the newborn.
    Voak D
    Vox Sang; 1969 Dec; 17(6):481-513. PubMed ID: 5373123
    [No Abstract]   [Full Text] [Related]  

  • 51. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 52. ABO hemolytic disease, complement, and phagocytosis.
    Gordon BD; Desforges J
    Pediatrics; 1972 Jul; 50(1):169. PubMed ID: 5038101
    [No Abstract]   [Full Text] [Related]  

  • 53. Isoimmune neonatal neutropenia.
    Boxer LA; Yokoyama M; Lalezari P
    J Pediatr; 1972 May; 80(5):783-7. PubMed ID: 4553087
    [No Abstract]   [Full Text] [Related]  

  • 54. [On the mode of action of immunoprevention with Anti-D immunoglobulin].
    Schneider W
    Geburtshilfe Frauenheilkd; 1969 Mar; 29(3):197-202. PubMed ID: 4180641
    [No Abstract]   [Full Text] [Related]  

  • 55. A new method for the detection of immune antibodies of the ABO system in maternal serum.
    Böttger JT
    Bibl Haematol; 1965; 23():869-74. PubMed ID: 5879450
    [No Abstract]   [Full Text] [Related]  

  • 56. Fetal blood group determination in amniotic cells.
    Vázquez-Escobosa C; Pérez-Medina R; Ramos-Damián ME; Gómez-Estrada H
    Arch Invest Med (Mex); 1982; 13(2):101-4 passim. PubMed ID: 6808946
    [No Abstract]   [Full Text] [Related]  

  • 57. Diagnosis, prevention, and therapy in hemolytic disease of the newborn.
    Polesky HF
    Clin Lab Med; 1982 Mar; 2(1):107-22. PubMed ID: 6821161
    [No Abstract]   [Full Text] [Related]  

  • 58. Diagnosis and treatment of the immune hemolytic anemias.
    Rosenfield RE; Diamond SH
    Haematologia (Budap); 1981; 14(3):247-56. PubMed ID: 7035308
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monogamous bivalency of IgG antibodies. I. Deficiency of branched ABHI-active oligosaccharide chains on red cells of infants causes the weak antiglobulin reactions in hemolytic disease of the newborn due to ABO incompatibility.
    Romans DG; Tilley CA; Dorrington KJ
    J Immunol; 1980 Jun; 124(6):2807-11. PubMed ID: 7189535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Development of immunobiological indicators in children with hyperbilirubinemia].
    Nejedlá Z
    Cesk Pediatr; 1969 Jul; 24(7):577-83. PubMed ID: 5805647
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.